Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Colwill

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|August 1, 2025
Proximity-dependent proteomics and network analysis of adenylyl cyclase isoforms 5, 6, and 9 in cardiomyocytesTaeyeop Park, Yong Li, Neha Arora, et al.
Analytica Chimica Acta|September 7, 2024
High-resolution quadrupole improves spectral purity and reduces interference from non-target ions in isobaric multiplexed quantitative proteomicsShen Zhang, J C Yves Le Blanc, Brett Larsen, et al.
BMC Infectious Diseases|February 2, 2024
Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, CanadaLucie Richard, Rosane Nisenbaum, Karen Colwill, et al.
BMC Biotechnology|March 8, 2006
Modification of the Creator recombination system for proteomics applications--improved expression by addition of splice sitesKaren Colwill, Clark D Wells, Kelly Elder, et al.
Journal of Virology|June 15, 2004
Myxoma virus M11L prevents apoptosis through constitutive interaction with BakGen Wang, John W Barrett, Steven H Nazarian, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 21, 2024
Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, OntarioMary Aglipay, Jeffrey C Kwong, Karen Colwill, et al.
Immunohorizons|November 24, 2025
Rapid decline of SARS-CoV-2-specific salivary IgA antibody levels in people with hybrid immunity-data from the STOPCoV studySharon L Walmsley, Majid Nabipoor, Gary Chao, et al.
Clinical Biochemistry|November 1, 2023
Evaluation of commercial assays for the assessment of SARS-CoV-2 antibody response in hemodialysis patientsAshley Di Meo, Liyan Ma, Kevin Yau, et al.
Pediatric Research|July 21, 2025
Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medicationsJanna R Shapiro, Florence Choi, Amy Xu, et al.
Microbiology Spectrum|February 16, 2022
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination HistorySteven J Drews, Queenie Hu, Reuben Samson, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|August 1, 2025
Proximity-dependent proteomics and network analysis of adenylyl cyclase isoforms 5, 6, and 9 in cardiomyocytesTaeyeop Park, Yong Li, Neha Arora, et al.
Analytica Chimica Acta|September 7, 2024
High-resolution quadrupole improves spectral purity and reduces interference from non-target ions in isobaric multiplexed quantitative proteomicsShen Zhang, J C Yves Le Blanc, Brett Larsen, et al.
BMC Infectious Diseases|February 2, 2024
Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, CanadaLucie Richard, Rosane Nisenbaum, Karen Colwill, et al.
BMC Biotechnology|March 8, 2006
Modification of the Creator recombination system for proteomics applications--improved expression by addition of splice sitesKaren Colwill, Clark D Wells, Kelly Elder, et al.
Journal of Virology|June 15, 2004
Myxoma virus M11L prevents apoptosis through constitutive interaction with BakGen Wang, John W Barrett, Steven H Nazarian, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 21, 2024
Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, OntarioMary Aglipay, Jeffrey C Kwong, Karen Colwill, et al.
Immunohorizons|November 24, 2025
Rapid decline of SARS-CoV-2-specific salivary IgA antibody levels in people with hybrid immunity-data from the STOPCoV studySharon L Walmsley, Majid Nabipoor, Gary Chao, et al.
Clinical Biochemistry|November 1, 2023
Evaluation of commercial assays for the assessment of SARS-CoV-2 antibody response in hemodialysis patientsAshley Di Meo, Liyan Ma, Kevin Yau, et al.
Pediatric Research|July 21, 2025
Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medicationsJanna R Shapiro, Florence Choi, Amy Xu, et al.
Microbiology Spectrum|February 16, 2022
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination HistorySteven J Drews, Queenie Hu, Reuben Samson, et al.
Pageof 8